BACKGROUND: Brain alterations in structure and function have been identified in people with risk factors for sporadic type Alzheimer's disease (AD), suggesting that alterations can be detected decades before AD diagnosis. Although the effect of apolipoprotein E (APOE) varepsilon4 on the brain is well-studied, less is known about the effect of family history of AD. We examined the main effects of family history and APOE varepsilon4 on brain integrity, in addition to assessing possible additive effects of these two risk factors. METHODS: Diffusion tensor imaging was performed in 136 middle-aged asymptomatic participants stratified on family history and APOE varepsilon4. Mean diffusivity and fractional anisotropy (FA) were entered in factorial analyses to test the effect of AD risk on microstructural brain integrity. We performed a post hoc analysis of the three principal diffusivities (lambda1, lambda2, lambda3) to provide potential additional insight on underlying tissue differences. RESULTS: Parental family history of AD was associated with lower FA in regions of the brain known to be affected by AD, including cingulum, corpus callosum, tapetum, uncinate fasciculus, hippocampus, and adjacent white matter. Contrary to previous reports, there was no main effect of APOE varepsilon4; however, there was an additive effect of family history and APOE varepsilon4 in which family history-positive participants who were also APOE varepsilon4 carriers had the lowest FA compared with the other groups. CONCLUSIONS: The data indicate that unknown risk factors contained in family history are associated with changes in microstructural brain integrity in areas of the brain known to be affected by AD. Importantly, the results provide further evidence that AD pathology might be detected before cognitive changes, perhaps decades before disease onset. Published by Elsevier Inc.
BACKGROUND: Brain alterations in structure and function have been identified in people with risk factors for sporadic type Alzheimer's disease (AD), suggesting that alterations can be detected decades before AD diagnosis. Although the effect of apolipoprotein E (APOE) varepsilon4 on the brain is well-studied, less is known about the effect of family history of AD. We examined the main effects of family history and APOE varepsilon4 on brain integrity, in addition to assessing possible additive effects of these two risk factors. METHODS: Diffusion tensor imaging was performed in 136 middle-aged asymptomatic participants stratified on family history and APOE varepsilon4. Mean diffusivity and fractional anisotropy (FA) were entered in factorial analyses to test the effect of AD risk on microstructural brain integrity. We performed a post hoc analysis of the three principal diffusivities (lambda1, lambda2, lambda3) to provide potential additional insight on underlying tissue differences. RESULTS: Parental family history of AD was associated with lower FA in regions of the brain known to be affected by AD, including cingulum, corpus callosum, tapetum, uncinate fasciculus, hippocampus, and adjacent white matter. Contrary to previous reports, there was no main effect of APOE varepsilon4; however, there was an additive effect of family history and APOE varepsilon4 in which family history-positive participants who were also APOE varepsilon4 carriers had the lowest FA compared with the other groups. CONCLUSIONS: The data indicate that unknown risk factors contained in family history are associated with changes in microstructural brain integrity in areas of the brain known to be affected by AD. Importantly, the results provide further evidence that AD pathology might be detected before cognitive changes, perhaps decades before disease onset. Published by Elsevier Inc.
Authors: Johanna Lind; Anne Larsson; Jonas Persson; Martin Ingvar; Lars-Göran Nilsson; Lars Bäckman; Rolf Adolfsson; Marc Cruts; Kristel Sleegers; Christine Van Broeckhoven; Lars Nyberg Journal: Neurosci Lett Date: 2006-01-06 Impact factor: 3.046
Authors: Andreas Fellgiebel; Matthias J Müller; Paulo Wille; Paulo R Dellani; Armin Scheurich; Lutz G Schmidt; Peter Stoeter Journal: Neurobiol Aging Date: 2005-01-12 Impact factor: 4.673
Authors: D H Salat; D S Tuch; A J W van der Kouwe; D N Greve; V Pappu; S Y Lee; N D Hevelone; A K Zaleta; J H Growdon; S Corkin; B Fischl; H D Rosas Journal: Neurobiol Aging Date: 2010-02 Impact factor: 4.673
Authors: Julie S Snowden; Cheryl L Stopford; Camille L Julien; Jennifer C Thompson; Yvonne Davidson; Linda Gibbons; Antonia Pritchard; Corinne L Lendon; Anna M Richardson; Anoop Varma; David Neary; David Mann Journal: Cortex Date: 2007-10 Impact factor: 4.027
Authors: Barbara B Bendlin; Michele L Ries; Mariana Lazar; Andrew L Alexander; Robert J Dempsey; Howard A Rowley; Jack E Sherman; Sterling C Johnson Journal: Neuroimage Date: 2008-05-07 Impact factor: 6.556
Authors: Lisa Mosconi; Wai Tsui; John Murray; Pauline McHugh; Yi Li; Schantel Williams; Elizabeth Pirraglia; Lidia Glodzik; Susan De Santi; Shankar Vallabhajosula; Mony J de Leon Journal: Neurobiol Aging Date: 2011-04-22 Impact factor: 4.673
Authors: Lisa Mosconi; Juha O Rinne; Wai H Tsui; John Murray; Yi Li; Lidia Glodzik; Pauline McHugh; Schantel Williams; Megan Cummings; Elizabeth Pirraglia; Stanley J Goldsmith; Shankar Vallabhajosula; Noora Scheinin; Tapio Viljanen; Kjell Någren; Mony J de Leon Journal: Neurobiol Aging Date: 2012-04-11 Impact factor: 4.673
Authors: Zaven S Khachaturian; Deborah Barnes; Richard Einstein; Sterling Johnson; Virginia Lee; Allen Roses; Mark A Sager; William R Shankle; Peter J Snyder; Ronald C Petersen; Gerard Schellenberg; John Trojanowski; Paul Aisen; Marilyn S Albert; John C S Breitner; Neil Buckholtz; Maria Carrillo; Steven Ferris; Barry D Greenberg; Michael Grundman; Ara S Khachaturian; Lewis H Kuller; Oscar L Lopez; Paul Maruff; Richard C Mohs; Marcelle Morrison-Bogorad; Creighton Phelps; Eric Reiman; Marwan Sabbagh; Mary Sano; Lon S Schneider; Eric Siemers; Pierre Tariot; Jacques Touchon; Bruno Vellas; Lisa J Bain Journal: Alzheimers Dement Date: 2010-03 Impact factor: 21.566
Authors: O C Okonkwo; G Xu; N M Dowling; B B Bendlin; A Larue; B P Hermann; R Koscik; E Jonaitis; H A Rowley; C M Carlsson; S Asthana; M A Sager; S C Johnson Journal: Neurology Date: 2012-05-16 Impact factor: 9.910
Authors: Jessica M Foley; David H Salat; Nikki H Stricker; Tyler A Zink; Laura J Grande; Regina E McGlinchey; William P Milberg; Elizabeth C Leritz Journal: Am J Alzheimers Dis Other Demen Date: 2013-12-31 Impact factor: 2.035
Authors: Wenjun Li; L Tugan Muftuler; Gang Chen; B Douglas Ward; Matthew D Budde; Jennifer L Jones; Malgorzata B Franczak; Piero G Antuono; Shi-Jiang Li; Joseph S Goveas Journal: J Neurol Sci Date: 2013-12-16 Impact factor: 3.181
Authors: K Kantarci; M L Senjem; R Avula; B Zhang; A R Samikoglu; S D Weigand; S A Przybelski; H A Edmonson; P Vemuri; D S Knopman; B F Boeve; R J Ivnik; G E Smith; R C Petersen; C R Jack Journal: Neurology Date: 2011-05-18 Impact factor: 9.910
Authors: Alex E Roher; Chera L Maarouf; Michael Malek-Ahmadi; Jeffrey Wilson; Tyler A Kokjohn; Ian D Daugs; Charisse M Whiteside; Walter M Kalback; Mimi P Macias; Sandra A Jacobson; Marwan N Sabbagh; Bernardino Ghetti; Thomas G Beach Journal: Am J Neurodegener Dis Date: 2013-09-18
Authors: Barbara B Bendlin; Lisa M Newman; Michele L Ries; Luigi Puglielli; Cynthia M Carlsson; Mark A Sager; Howard A Rowley; Catherine L Gallagher; Auriel A Willette; Andrew L Alexander; Sanjay Asthana; Sterling C Johnson Journal: Front Aging Neurosci Date: 2010-09-03 Impact factor: 5.750